Preparation of intact hexahydrobenzofuran subunits of ivermectin by selective ozonolysis of the Δ3,4-intermediate secoester

European Journal of Organic Chemistry

Volumn , Issue 15, 2005, Pages 3348-3359

  Dos Santos, Anderson Rouge ^a   Ferreira, Maria De Lourdes Garcia ^b   Kaiser, Carlos R ^a   Férézou, Jean Pierre ^c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Instituto de Pesquisa e Desenvolvimento de Produtos Farmacêuticos   (Brazil)

Author keywords

Antibiotics; Chemoselectivity; Natural products; Ozonolysis; Transesterification

Indexed keywords

EID: 23044449122     PISSN: 1434193X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ejoc.200500033     Document Type: Article

References (68)

1. W. L. Shoop, H. Mrozik, M. H. Fisher, Vet. Parasitol. 1995, 59, 139-156.
2. S. Omura, A. Crump, Nat. Rev. Microbiol. 2004, 2, 984-989.
3. a) E. A. Ottesen, W. C. Campbell, J. Antimicrob. Chemother. 1994, 34, 195-203;
4. b) K. R. Brown, F. M. Ricci, E. A. Ottesen, Parasitology 2000, 121, S133-S146;
5. c) D. Richard-Lenoble, J. Chandenier, P. Gaxotte, Fundam. Clin. Pharmacol. 2003, 17, 199-203;
6. d) D. H. Molyneux, M. Bradley, A. Hoerauf, D. Kyelem, M. J. Taylor, Trends Parasitol. 2003, 19, 516-522. See also http://www.who.in.
7. For reviews, see:a) M. H. Fisher, The Avermectins, in Recent Advances in the Chemistry of Insect control (Ed.: N. F. Janes), The Royal Society of Chemistry, Special Edition, London, 1985, p. 53;
8. b) H. G. Davies, R. H. Green, Nat. Prod. Rep. 1986, 3, 87-121;
9. c) M. T. Crimmins, W. G. Hollis, R. O'Mahony, in Studies in Natural Products Chemistry, vol. 1, Stereoselective Synthesis Part A (Ed.: Atta-Ur-Rahman), Elsevier, 1988, p. 435;
10. d) T. Blizzard, M. H. Fisher, H. Mrozik, T. L. Shih, in Recent Progress in the Chemical Synthesis of Antibiotics (Eds.: G. Lukacs, M. Ohno), Springer-Verlag, New York, 1990, p. 65;
11. e) G. Davies, R. H. Green, Chem. Soc. Rev. 1991, 20, 211-269;
12. f) G. Davies, R. H. Green, Chem. Soc. Rev. 1991, 271-339;
13. g) T. A. Blizzard, Org. Prep. Proced. Int. 1994, 26, 619-644.
14. a) S. Hanessian, A. Ugolini, D. Dubé, P. J. Hodges, C. André, J. Am. Chem. Soc. 1986, 108, 2776-2778;
15. b) S. Hanessian, A. Ugolini, P. J. Hodges, P. Beaulieu, D. Dubé, C. André, Pure Appl. Chem. 1987, 59, 299-316;
16. c) A. Armstrong, S. V. Ley, Synlett 1990, 323-325;
17. d) D. Diez-Martin, P. Grice, H. C. Kolb, S. V. Ley, A. Madin, Synlett 1990, 326-328;
18. e) A. Armstrong, S. V. Ley, A. Madin, S. Mukherjee, Synlett 1990, 328-330;
19. f) S. V. Ley, A. Armstrong, D. Diez-Martin, M. J. Ford, P. Grice, J. G. Knight, H. C. Kolb, A. Madin, C. A. Marby, S. Mukherjee, A. N. Shaw, A. M. Z. Slawin, S. Vile, A. D. White, D. J. Williams, M. Woods, J. Chem. Soc., Perkin Trans. 1 1991, 667-692;
20. g) J. D. White, G. L. Bolton, J. Am. Chem. Soc. 1990, 112, 1626-1628 (aglycon);
21. h) J. D. White, G. L. Bolton, A. P. Dantanarayana, C. M. Fox, R. N. Hiner, R. W. Jackson, K. Sakuma, U. S. Warrier, J. Am. Chem. Soc. 1995, 117, 1908-1939.
22. a) S. J. Danishefsky, D. M. Armistead, F. E. Wincott, H. G. Selnick, R. Hungate, J. Am. Chem. Soc. 1987, 109, 8117-8119 (aglycon);
23. b) S. J. Danishefsky, D. M. Armistead, F. E. Wincott, H. G. Selnick, R. Hungate, J. Am. Chem. Soc. 1989, 111, 2967-2980.
24. 1: M. Hirama, T. Noda, S. Yasuda, S. Itô, J. Am. Chem. Soc. 1991, 113, 1830-1832;
25. b) Milbemycin D: M. T. Crimmins, R. S. Al-Awar, I. M. Vallin, W. G. Hollis, R. O'Mahony, J. G. Lever, D. M. Bankaitis-Davis, J. Am. Chem. Soc. 1996, 118, 7513-7528.
26. J.-P. Férézou, M. Julia, Y. Li, L. W. Liu, A. Pancrazi, Bull. Soc. Chim. Fr. 1995, 132, 428-452.
27. a) N. C. Sangster, Int. J. Parasitol. 1999, 29, 115-124;
28. b) Q. A. McQuellar, F. Jackson, Trends Parasitol. 2004, 20, 456-461.
29. P. T. Meinke, J. Med. Chem. 2001, 44, 641-659 and references cited therein.
30. Macrocyclic Lactones in Antiparasitic Therapy (Eds.: R. S. Rew, J. Vercruysse), CABI Publishing, New York, NY, 2002.
31. a) A. P. Kozikowski, K. E. MaloneyHuss, Tetrahedron Lett. 1985, 26, 5759-5762;
32. b) M. Prashad, B. Fraser-Reid, J. Org. Chem. 1985, 50, 1564-1566;
33. c) S. Hanessian, P. Beaulieu, D. Dubé, Tetrahedron Lett. 1986, 27, 5071-5074;
34. d) R. E. Ireland, D. M. Obrecht, Helv. Chim. Acta 1986, 69, 1273-1286;
35. e) M. T. Crimmins, W. G. Hollis, J. G. Lever, Tetrahedron Lett. 1987, 28, 3647-3650;
36. f) M. Hirama, T. Noda, S. Itô, C. Kabuto, J. Org. Chem. 1988, 53, 706-708;
37. g) M. E. Jung, V. C. Truc, Tetrahedron Lett. 1988, 29, 6059-6062 and references cited therein;
38. h) P. J. Parsons, P. A. Willis, S. C. Eyley, J. Chem. Soc., Chem. Commun. 1988, 283-285;
39. i) D. R. Williams, F. D. Klinger, J. Org. Chem. 1988, 53, 2134-2136;
40. j) D. R. Williams, F. D. Klinger, V. Dabral, Tetrahedron Lett. 1988, 29, 3415-3418;
41. k) A. G. M. Barrett, T. E. Barta, J. A. Flygare, M. Sabat, C. D. Spilling, J. Org. Chem. 1990, 55, 2409-2414;
42. S. Fugiwara, A. B. Smith III, Tetrahedron Lett. 1992, 33, 1185-1188;
43. C.-K. Sha, S.-J. Huang, Z.-P. Zhan, J. Org. Chem. 2002, 67, 831-836.
44. Generic Ivermectin is currently available in bulk quantities at a reasonable price.
45. J. C. Chabala, H. Mrozik, R. L. Tolman, P. Eskola, A. Lusi, L. H. Peterson, M. F. Woods, M. H. Fisher, J. Med. Chem. 1980, 23, 1134-1136.
46. S. Hanessian, A. Ugolini, P. J. Hodges, D. Dubé, Tetrahedron Lett. 1986, 27, 2699-2702.
47. a) S. Hanessian, A. Ugolini, D. Dubé, P. J. Hodges, C. André, J. Am. Chem. Soc. 1986, 108, 2776-2778;
48. b) S. Hanessian, A. Ugolini, P. J. Hodges, P. Beaulieu, D. Dubé, C. André, Pure Appl. Chem. 1987, 59, 299-316.
49. a) The deconjugation procedure was found to be difficult to reproduce and was therefore subjected to complementary studies: S. Hanessian, D. Dubé, P. J. Hodges, J. Am. Chem. Soc. 1987, 109, 7063-7067;
50. b) B. Fraser-Reid, H. Wolleb, R. Faghih, J. Barchi Jr., J. Am. Chem. Soc. 1987, 109, 933-935.
51. a) Conversion of Avermectin B1a to a 19-epi Avermectin A1a: S. Hanessian, P. Chemla, Tetrahedron Lett. 1991, 32, 2719-2722;
52. 2 double bond.
53. A. B. Smith III, A. S. Thompson, Tetrahedron Lett. 1985, 26, 4279-4282.
54. a) J.-P. Férézou, M. Julia, L. W. Liu, A. Pancrazi, Synlett 1991, 618-620;
55. [8]. This methodology has also been used by Merck's group: b) P. T. Meinke, B. Arison, J. C. Culberson, M. H. Fisher, H. Mrozik, J. Org. Chem. 1998, 63, 2591-2596.
56. G. Albers-Schönberg, B. H. Arison, J. C. Chabala, A. W. Douglas, P. Eskola, M. H. Fisher, A. Lusi, H. Mrozik, J. L. Smith, R. L. Tolman, J. Am. Chem. Soc. 1981, 103, 4216-4221.
57. [15]
58. D. Seebach, E. Hungerbühler, R. Naef, P. Schnurrenberger, B. Weidmann, M. Züger, Synthesis 1982, 138-141.
59. [20b] and S. Bailey, A. Teerawutgulrag, E. J. Thomas, J. Chem. Soc., Chem. Commun. 1995, 2521-2522.
60. [23]).
61. a) P. S. Bailey, Ozonation in Organic Chemistry, Academic Press, New York, 1978 (vol. 1);
62. b) For an example with allylic alcohols, see: M. P. DeNinno, J. Am. Chem. Soc. 1995, 117, 9927-9928.
63. Due to potential explosion hazard, evaporation of samples of ozonides was carried out with the minimum amount required for further analysis, behind a safety shield, and without heating.
64. a) R. Criegee, Rec. Chem. Proc. 1957, 18, 111-120;
65. R. Criegee, Angew. Chem. 1975, 87, 765-771;
66. Angew. Chem. Int. Ed. Engl. 1975, 14, 745-762;
67. b) For a recent investigation on this mechanism, see: R. Ponec, G. Yuzhakov, Y. Haas, U. Samuni, J. Org. Chem. 1997, 62, 2757-2762.
68. [8].